Elicio Therapeutics, Inc. · NASDAQ:ELTX
Actyus Private Equity SGIIC, S.A. reported a 5.40% stake in Elicio Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 14, 2025
Actyus Private Equity SGIIC, S.A. reported a 5.40% stake in Elicio Therapeutics, Inc., 856,382 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G/A).
- Stake
- 5.40%
- Shares
- 856,382
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Actyus Private Equity SGIIC, S.A. | 5.40% | 856,382 |
Source
Related
- Elicio Therapeutics, Inc.
- Actyus Private Equity SGIIC, S.A.
- Elicio Therapeutics, Inc. shareholders
- Schedule 13G/A · Actyus Private Equity SGIIC, S.A. · Oct 7, 2025
- Schedule 13G · Actyus Private Equity SGIIC, S.A. · Jan 7, 2025
- Schedule 13G · Moti Investments LLC · Jul 16, 2026
- Schedule 13G/A · Knoll Capital Management, LLC · Jul 8, 2026
- Schedule 13D/A · Gkcc, LLC · Jun 4, 2025
- Schedule 13D/A · Chudnovsky Yekaterina · Mar 7, 2025
- Schedule 13G · Knoll Capital Management, LLC · Feb 5, 2025